← Russell 3000 cross-section

ALHC Alignment Healthcare, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-07-30, not restated
Financials

Scale

Market cap
$2.9bn
Revenue TTM
$4.6bn
Net income TTM
$41m
Free cash flow
$178m
Composite score
51.3
Sector rank
#1425

Valuation

P / E
71.2
EV / EBITDA
29.1
EV / sales
0.6
FCF yield
6.13%
Earnings yield vs 10-yr
-3.32pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
0.9%
EBITDA margin
1.9%
ROE
15.3%
ROIC
Revenue growth
37.2%

Insider activity, last 90 days

Net open-market
$-23.23m
Buyers
1
Sellers
4

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Revenue and Accounts Receivable Earned premium revenue consisted of premium revenue and capitation revenue for the three and six months ended June 30, 2026 and 2025 were as follows: Premium revenue is derived monthly from the federal government based on our contracts with the Centers for Medicare and Medicaid Services (“CMS”). In 2025, capitation revenue consisted primarily of capitated fees for medical care services provided by us under arrangements with third-party payors. As a result of this arrangement, ACO revenue was recorded on a net basis within other revenue on the condensed consolidated statement of operations. …Alignment Healthcare, Inc., 10-Q, period ended 2026-06-30, filed 2026-07-30

Read the full passage →